In our previous study, NR2E3 emerged as a host factor that activates p53 in E6+ cervical cancer HeLa cells, identified through a high-throughput screen of 16,000 human and mouse cDNAs [20]. This evidence concerns the gene TP53 and cervical carcinoma.